Pfizer Post Loss on Higher Revenue

Pfizer swung to a second-quarter loss but posted higher revenue, as market growth in its oncology business offset some declines in its Covid-19 products.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。